We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Shield

News List

PolyPid Announces Start of Phase 3 Clinical Trial of D-PLEX100 americanpharmaceuticalreview
March 04, 2020
PolyPid announced that the first patient has been enrolled and randomized in a Phase 3 clinical trial called SHIELD (Surgical site Hospital acquired Infection prEvention with Local D-plex).
Astellas, Sunovion and Shield breach ABPI Code pharmatimes
December 19, 2018
The Prescription Medicines Code of Practice Authority (PMCPA) has announced that Astellas Pharmaceuticals, Sunovion Pharmaceuticals and Shield Therapeutics have all breached the Association
Shield expecting US decision on Feraccru in July pharmatimes
December 14, 2018
Shield Therapeutics has revealed that the US Food and Drug Administration will make a decision on its application to market Feraccru in the US by July 27 next year.
Shield’s Feraccru accepted for review in the US pharmatimes
December 06, 2018
Shield Therapeutics’ iron deficiency drug Feraccru has been accepted for review by the US Food and Drug Administration (FDA).